PAPA Medical Inc.
PAPA
NASDAQ
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 71.21% | 4.66% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 71.21% | 4.66% | |||
| Cost of Revenue | 80.52% | 1.82% | |||
| Gross Profit | 45.12% | 13.51% | |||
| SG&A Expenses | -2.85% | 57.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 56.97% | 12.96% | |||
| Operating Income | 363.55% | -184.10% | |||
| Income Before Tax | 320.79% | -210.99% | |||
| Income Tax Expenses | 186.08% | -341.76% | |||
| Earnings from Continuing Operations | 523.34% | -161.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 523.34% | -161.22% | |||
| EBIT | 363.55% | -184.10% | |||
| EBITDA | 28,147.50% | -99.15% | |||
| EPS Basic | 524.73% | -161.18% | |||
| Normalized Basic EPS | 377.12% | -190.08% | |||
| EPS Diluted | 524.73% | -161.18% | |||
| Normalized Diluted EPS | 377.12% | -190.08% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||